As the rate of myopia in children grows, research is keeping a finger pointed at the fact much of our lives is spent indoors.

After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...

Regeneron (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced Friday that the U.S. FDA approved a label expansion for its asthma ...

On Friday, the FDA approved Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) ...

The Food and Drug Administration is expected to approve the first new type of drug for schizophrenia in decades. Called KarXT, the medicine appears to be effective, but its main advantage over current ...

Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, a new ...

The U.S. Food and Drug Administration (FDA) passed a critical mandate regarding dense breast tissue. Here's what it means for ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

FDA alerts in gastroenterology over the summer included an approval for a biosimilar for IBD & new indications for nonerosive ...

The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...

Intermountain Medical Center in Murray has made medical history as the first hospital in the United States to perform a new ...

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.